Stockreport

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer's and Dementia [Yahoo! Finance]

Nexalin Technology, Inc.  (NXL) 
PDF the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No 12,011,591 relating to the Company's non-invasive Deep Intracranial Frequency Stimulatio [Read more]